# Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)

> **NCT07481656** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 160 (estimated)

## Conditions studied

- Acute Brain Injuries
- Moderate to Severe Traumatic Brain Injury

## Interventions

- **DRUG:** Recombinant Human Growth Hormone (rhGH) Injection
- **OTHER:** Standard Care (Treatment as Usual)

## Key facts

- **NCT ID:** NCT07481656
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-10
- **Primary completion:** 2027-09-30
- **Final completion:** 2028-10-30
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-03-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07481656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07481656, "Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07481656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*